摘要
目的:探讨对于小儿哮喘急性发作采用高低剂量布地奈德混悬液雾化吸入进行治疗的临床效果。方法:将本院近期收治的75例小儿哮喘急性发作期患儿根据入院先后分为高剂量组(39例)与低剂量组(36例),两组患儿均在常规综合治疗基础之上进行,低剂量组给予布地奈德混悬液0.5mg/次雾化吸入,高剂量组给予布地奈德混悬液1.0mg/次,比较两组患儿的临床疗效。结果:两组治疗后24h、72h组间比较及各组前后临床表现评分比较差异具有统计学意义(P<0.05),治疗72h两组PEF、FEV1治疗前后及治疗后组间比较差异具有统计学意义(P<0.05)。结论:对于小儿哮喘急性发作期采用高剂量布地奈德混悬液雾化吸入起效迅速,同时有着较高的安全性,值得在临床上推广使用。
Objective：To explore for children with asthma acute attack with high and low dose of budesonide suspension liquid atomization inhalation treatment the clinical effect.Method：Our hospital recent treated 75 cases of pediatric asthma children with acute phase according to the hospital,who were divided into the high dose group（39 cases）and low dose group（36 cases）,two groups of children were conducted on the basis of routine comprehensive treatment and low dose groups given budesonide suspension liquid atomization inhalation of 0.5 mg/time,high dose group of budesonide suspension liquid for a 1.0 mg/time,compared the clinical curative effect of two groups of children.Result：Two groups of 24 h,72 h after treatment group before and after the rush compared between each group was statistically significant（P 0.05）,treatment for 72 h two groups of PEF,FEV 1 and components before and after each comparison with statistical difference（P 0.05）. Conclusion：For pediatric asthma acute phase using high dose of budesonide suspension liquid atomization inhalation effect quickly,at the same time have higher security,is worth popularizing in clinical use.
出处
《中国医学创新》
CAS
2013年第22期116-117,共2页
Medical Innovation of China
关键词
小儿哮喘
急性发作期
布地奈德混悬液
高剂量
雾化吸入
Pediatric asthma
Acute phase
Budesonide mixed suspension
High dose
Atomization inhalation
